Policy Analysis: Investment, Life Sciences, Policy

Pharma industry agrees collaboration to tackle non-communicable disease

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.

Image: Bigstock

The industry’s ten-point framework scopes out specific areas of action including innovation, access and affordability of drugs, prevention and health education. It also underscores the essential role of partnerships and dialogue in implementing the framework.

The framework confirms the industry’s crucial role in continued investment in R&D programmes to develop drugs for the prevention and treatment of non-communicable disease, with over 1,500 products in the pipeline currently. It also commits the industry to target its innovation towards...

Related subjects: Cancer, Diabetes, chronic respiratory disease, non-communicable disease

Views of 2030: Transport, manufacturing, education and health
In October 2014, members of the Science|Business Network of universities and companies met in Berlin to compare notes about the future of four key sectors in Europe. This is what they see coming.